Programme Introduction
About this programme
💊 Pharmacy Practice
✅ Regulatory & Clinical
📋 Case-Based Learning
Adverse Drug Reaction (ADR) monitoring is the systematic process of detecting, assessing and preventing harmful, unintended responses to medicines given at normal therapeutic doses. In hospitals — especially intensive care units, oncology wards and polypharmacy-heavy settings — the risk of ADRs rises sharply, making structured monitoring a patient-safety necessity rather than an optional exercise.
ADR monitoring sits at the heart of pharmacovigilance, connecting clinical pharmacy, therapeutics and regulatory reporting into one continuous safety loop that protects patients and improves prescribing practice over time.
TerraLeap’s course trains learners to recognise a suspected ADR, apply a structured causality assessment, grade its severity, and complete the reporting steps expected of hospital pharmacovigilance programmes.
Learners finish able to run through an ADR from first suspicion to formal report with clinical confidence.
Clinical and regulatory expertise — built for real pharmacy practice.
Programme Scope
What this programme covers
The course follows a suspected ADR from detection through causality assessment to formal reporting within a hospital pharmacovigilance system.
🔍
ADR detection
Recognising signs of a suspected adverse drug reaction on the ward.
⚖️
Causality assessment
Applying structured scales to judge how likely a drug is to be responsible.
📈
Severity & preventability grading
Classifying how serious a reaction is and whether it could have been avoided.
📝
Reporting workflows
Completing hospital and regulatory pharmacovigilance reporting formats correctly.
🏥
High-risk hospital settings
Special monitoring considerations for ICUs, oncology wards and polypharmacy patients.
🌍
National pharmacovigilance alignment
How hospital-level monitoring feeds into broader drug-safety programmes.
Learning Objectives
What you will achieve
The course focuses on the practical steps a hospital pharmacist or drug-safety professional takes when an ADR is suspected.
By the end of the course you will be able to:
01
Recognise a suspected ADR promptly against a patient’s clinical presentation.
02
Apply a causality assessment scale to determine the likelihood of drug involvement.
03
Grade severity and preventability of a confirmed adverse reaction.
04
Complete accurate ADR reports for hospital and national pharmacovigilance systems.
05
Identify high-risk patients and settings where ADR vigilance should be heightened.
06
Recommend prescribing changes that reduce the risk of recurrence.
Target Audience
Who can enroll
This ADR monitoring course is designed for pharmacy and hospital drug-safety professionals responsible for detecting, assessing and reporting adverse drug reactions.
It also suits clinical staff in high-risk wards where polypharmacy and complex regimens raise the likelihood of drug-related harm.
🏥
Hospital pharmacists coordinating pharmacovigilance activities.
🎓
Pharm.D and clinical pharmacy students building drug-safety skills.
🩺
Nurses and physicians in ICU and oncology settings observing at-risk patients.
📋
Pharmacovigilance coordinators managing hospital reporting programmes.
📚
Pharmacy educators teaching pharmacovigilance and drug-safety principles.
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Adverse Drugs Reaction Monitoring in Hospitals
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.